Filing Details
- Accession Number:
- 0001209191-19-031213
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-05-20 07:18:18
- Reporting Period:
- 2019-05-16
- Accepted Time:
- 2019-05-20 07:18:18
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 818686 | Teva Pharmaceutical Industries Ltd | TEVA | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1719114 | Carlo Notaristefani De | C/O Teva Pharmaceutical Industries Ltd. 5 Basel Street Petach Tikva L3 4951033 | Executive Vp Global Operations | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Acquisiton | 2019-05-16 | 1,204 | $0.00 | 19,413 | No | 4 | M | Direct | |
| Ordinary Shares | Disposition | 2019-05-16 | 629 | $11.76 | 18,784 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Ordinary Shares | Restricted Share Units | Disposition | 2019-05-16 | 1,204 | $0.00 | 1,204 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | No | 4 | M | Direct |
Footnotes
- The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
- The Ordinary Shares were received for no consideration upon the satisfaction of performance criteria underlying an award of performance share units.
- The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted share units listed in Table II.
- Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share.
- Restricted share units were granted on February 12, 2019 pursuant to the satisfaction of performance criteria and vested on May 16, 2019.
Billionaire Hedge Funds
